Ontx stock
Web24 de mar. de 2024 · Company Description. Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological ... WebOnconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage …
Ontx stock
Did you know?
Web6 de abr. de 2024 · markets.businessinsider.com - March 23 at 1:22 PM. Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify Biomarkers of Response to Rigosertib. finance.yahoo.com - March 23 at 1:22 PM. Onconova Therapeutics, Inc. (NASDAQ:ONTX) Expected to Post Q1 2024 Earnings of ($0.27) Per … WebGet the latest Onconova Therapeutics Inc (ONTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …
Web11 de abr. de 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Onconova Therapeutics stock is Buy based on the current 1 buy rating for ONTX. The average twelve-month price prediction for Onconova Therapeutics is $11.00 with a high price target of $11.00 and a low price target of $11.00. WebONTX Complete Onconova Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
WebFind the latest ON24, Inc. (ONTF) stock quote, history, news and other vital information to help you with your stock trading and investing. WebStock prices follow Earnings Per Share, which are trending downward. 2014 2016 2024 2024. ONTX. ... ONTX is a good value based on its PE Ratio compared to the Pharma average. 2014 2016 2024 2024.
Web8 de abr. de 2024 · Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a …
WebThe current ONTX stock price $0.6731 has increased 7.89% from its 52-week low Does ONTX stock pay dividends? No, the ONTX stock does not pay dividends to its shareholders graphic device crash mhwWeb20 de mai. de 2024 · Onconova’s common stock will continue to trade on the Nasdaq Capital Market under the trading symbol “ONTX.” The new CUSIP number for the common stock following the reverse stock split is ... chirofusion blank formsWeb102 linhas · Discover historical prices for ONTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Onconova Therapeutics, Inc. stock was issued. 몬헌 graphic device crashedWebHá 1 dia · Find the latest Price To Free Cash Flow for Onconova Therapeutics (ONTX) Skip to main content. We use cookies to understand how ... That means you want to buy stocks with a Zacks Rank #1 or #2, ... graphic device driver updateWeb10 de abr. de 2024 · Onconova Therapeutics, Inc. (ONTX) Reports Q2 Loss, Lags Revenue Estimates. Onconova Therapeutics, Inc. (ONTX) delivered earnings and revenue … chirofuif tremeloWebView the real-time ONTX price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non ... You can buy and sell Onconova Therapeutics (ONTX) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial ... graphic dialog boxWebONTX has a Quality Grade of D, ranking ahead of 8.68% of graded US stocks. ONTX's asset turnover comes in at 0.007 -- ranking 403rd of 682 Pharmaceutical Products … graphic device error code 22